NCT06968793

Brief Summary

During pressure support ventilation (PSV), monitoring of Esophageal Pressure (Pes) has long been considered the gold standard for assessing intrathoracic pressure and the state of respiratory mechanics.The aim of this study was to investigate the correlation between Cuff Pressure (Pcuff) and Esophageal Pressure in patients undergoing tracheal intubation or tracheotomy, and to assess whether Pcuff can be used as a surrogate for Pes for reflecting changes in intrathoracic pressure.The correlation and its consistency between the two under different ventilation conditions were analysed by synchronously monitoring the ΔPcuff and ΔPes to further validate the potential application value of cuff pressure in clinical practice.The results of the study will provide a more convenient and non-invasive method of monitoring intrathoracic pressure in mechanically ventilated patients, thus optimising ventilation strategies, reducing complications, and promoting the innovation and development of monitoring technology in the field of critical care medicine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

May 20, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 21, 2026

Status Verified

May 1, 2025

Enrollment Period

8 months

First QC Date

May 5, 2025

Last Update Submit

January 19, 2026

Conditions

Keywords

Esophageal pressuremechanical ventilationEndotracheal tube cuff pressureinspiratory effort

Outcome Measures

Primary Outcomes (4)

  • Tidal swing of endotracheal tube cuff pressure (ΔPcuff)

    Tidal swing of endotracheal tube cuff pressure (ΔPcuff) will be measured.

    From enrollment to the end of treatment at 4 hours

  • Tidal swing of esophageal pressure (∆Pes)

    Tidal swing of esophageal pressure (∆Pes) will be measured.

    From enrollment to the end of treatment at 4 hours

  • Esophageal pressure-time product (PTP)

    Esophageal pressure-time product (PTP) will be measured.

    From enrollment to the end of treatment at 4 hours

  • Inspiratory muscle pressure (Pmus)

    Inspiratory muscle pressure (Pmus) will be measured.

    From enrollment to the end of treatment at 4 hours

Secondary Outcomes (2)

  • Occluded airway pressure at 100ms (P0.1)

    From enrollment to the end of treatment at 4 hours

  • Maximal decrease of airway pressure during end-expiratory occlusion (∆Pocc)

    From enrollment to the end of treatment at 4 hours

Study Arms (6)

Pressure support 15

EXPERIMENTAL

Pressure support of 15 cm H2O will be applied for 5 minutes.

Procedure: Pressure support 15

Pressure support 13

EXPERIMENTAL

Pressure support of 13 cm H2O will be applied for 5 minutes.

Procedure: Pressure support 13

Pressure support 11

EXPERIMENTAL

Pressure support of 11 cm H2O will be applied for 5 minutes.

Procedure: Pressure support 11

Pressure support 9

EXPERIMENTAL

Pressure support of 9 cm H2O will be applied for 5 minutes.

Procedure: Pressure support 9

Pressure support 7

EXPERIMENTAL

Pressure support of 7 cm H2O will be applied for 5 minutes.

Procedure: Pressure support 7

Pressure support 5

EXPERIMENTAL

Pressure support of 5 cm H2O will be applied for 5 minutes.

Procedure: Pressure support 5

Interventions

Pressure support of 13 cm H2O will be applied for 5 minutes.

Pressure support 13

Pressure support of 11 cm H2O will be applied for 5 minutes.

Pressure support 11

Pressure support of 7 cm H2O will be applied for 5 minutes.

Pressure support 7

Pressure support of 5 cm H2O will be applied for 5 minutes.

Pressure support 5

Pressure support of 15 cm H2O will be applied for 5 minutes.

Pressure support 15

Pressure support of 9 cm H2O will be applied for 5 minutes.

Pressure support 9

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mechanically ventilated patients who can tolerate pressure support ventilation (PSV) mode;
  • Respiratory stability: Ability to breathe spontaneously and effectively clear secretions via coughing; oxygen saturation (SpO₂) \>90% or a partial pressure of oxygen (PaO₂)/FiO₂ ratio ≥150 mmHg when the ventilator's oxygen concentration is set to 40%;
  • Hemodynamic stability: Heart rate (HR) ≤120 bpm, systolic blood pressure (SBP) 90-150 mmHg, with no vasoactive agents or norepinephrine dosage ≤0.1-0.2 μg/kg·min (or equivalent doses of other vasoactive agents);
  • Metabolic stability, with an esophageal pressure monitoring catheter already placed prior to the trial;
  • Written informed consent obtained from the patient or their legal guardian.

You may not qualify if:

  • Age \<18 years;
  • Pregnancy;
  • Hemodynamic instability: Mean arterial pressure (MAP) \<60 mmHg, heart rate (HR) \>120 bpm or \<60 bpm;
  • Respiratory instability: Respiratory rate (RR) \>35 bpm or oxygen saturation (SpO₂) \<90%;
  • Neuromuscular disorders or phrenic nerve injury;
  • Recent trauma or surgery involving the trachea, esophagus, neck, or thorax, contraindications to esophageal catheter insertion, or inability to monitor esophageal pressure;
  • High bleeding risk: Severe coagulopathy/bleeding disorders, esophageal/gastric varices, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Shijitan Hospital

Beijing, Beijing Municipality, 100038, China

Location

Study Officials

  • Jian-Xin Zhou, MD, PhD

    Capital Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Emergency and Critical Care Center

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 13, 2025

Study Start

May 20, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 21, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations